Skip to content
10-Q/A

Quarterly Report

SANGUI BIOTECH INTERNATIONAL INC

0001096906-21-001061

← back to feed
Filed
May 7, 2021 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · May 7, 2021 206.9M sh
Capex Q3 2021 · Mar 31, 2021 $0
Capex Q3 2021 · Mar 31, 2020 $3.1K
Operating Cash Flow Q3 2021 · Mar 31, 2021 −$104.18K
Operating Cash Flow Q3 2021 · Mar 31, 2020 −$128.15K
Short Term Debt Q3 2021 · Mar 31, 2021 $745.96K
Short Term Debt Q3 2021 · Jun 30, 2020 $618.57K
Cash And Equivalents Q3 2021 · Mar 31, 2021 $11.62K
Cash And Equivalents Q3 2021 · Jun 30, 2020 $15.28K
Cash And Equivalents Q3 2021 · Mar 31, 2020 $11.57K
Cash And Equivalents Q3 2021 · Jun 30, 2019 $27.45K
Stockholders Equity Q3 2021 · Mar 31, 2021 −$233.22K
Stockholders Equity Q3 2021 · Jun 30, 2020 −$82.9K
Current Liabilities Q3 2021 · Mar 31, 2021 $952.19K
Current Liabilities Q3 2021 · Jun 30, 2020 $791.49K
Total Liabilities Q3 2021 · Mar 31, 2021 $1.01M
Total Liabilities Q3 2021 · Jun 30, 2020 $855.21K
Current Assets Q3 2021 · Mar 31, 2021 $54.57K
Current Assets Q3 2021 · Jun 30, 2020 $48.7K
Total Assets Q3 2021 · Mar 31, 2021 $126.32K
Total Assets Q3 2021 · Jun 30, 2020 $125.33K
Sga Expense Q3 2021 · Mar 31, 2021 $14.33K
Sga Expense Q3 2021 · Mar 31, 2021 $37.95K
Sga Expense Q3 2021 · Mar 31, 2020 $8.59K
Sga Expense Q3 2021 · Mar 31, 2020 $28.68K
Rd Expense Q3 2021 · Mar 31, 2021 $2.06K
Rd Expense Q3 2021 · Mar 31, 2021 $6.48K
Rd Expense Q3 2021 · Mar 31, 2020 $1.54K
Rd Expense Q3 2021 · Mar 31, 2020 $6.42K
Net Income Q3 2021 · Mar 31, 2021 −$90
Net Income Q3 2021 · Mar 31, 2021 −$148.87K
Net Income Q3 2021 · Mar 31, 2020 −$26.7K
Net Income Q3 2021 · Mar 31, 2020 −$123.43K
Operating Income Q3 2021 · Mar 31, 2021 −$28.33K
Operating Income Q3 2021 · Mar 31, 2021 −$111.04K
Operating Income Q3 2021 · Mar 31, 2020 −$37.46K
Operating Income Q3 2021 · Mar 31, 2020 −$129.89K
Gross Profit Q3 2021 · Mar 31, 2021 $21.18K
Gross Profit Q3 2021 · Mar 31, 2021 $51.75K
Gross Profit Q3 2021 · Mar 31, 2020 $9.21K
Gross Profit Q3 2021 · Mar 31, 2020 $21.18K
Revenue Q3 2021 · Mar 31, 2021 $21.18K
Revenue Q3 2021 · Mar 31, 2021 $51.75K
Revenue Q3 2021 · Mar 31, 2020 $9.21K
Revenue Q3 2021 · Mar 31, 2020 $21.18K